DE69831805D1 - Dextranderivate, verfahren zu deren herstellung und verwendungen als arzneimittel mit spezifischer, biologischer wirkung - Google Patents

Dextranderivate, verfahren zu deren herstellung und verwendungen als arzneimittel mit spezifischer, biologischer wirkung

Info

Publication number
DE69831805D1
DE69831805D1 DE69831805T DE69831805T DE69831805D1 DE 69831805 D1 DE69831805 D1 DE 69831805D1 DE 69831805 T DE69831805 T DE 69831805T DE 69831805 T DE69831805 T DE 69831805T DE 69831805 D1 DE69831805 D1 DE 69831805D1
Authority
DE
Germany
Prior art keywords
groups
equal
preparation
specific biological
homogeneity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69831805T
Other languages
English (en)
Other versions
DE69831805T2 (de
Inventor
Frederic Chaubet
Remi Huynh
Latifa Dahri
Jose Correia
Marcel Jozefowicz
Jacqueline Jozefonvicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biodex SARL
Original Assignee
BIODEX ST AMAND LES EAUX
BIODEX ST AMAND LES EAUX
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIODEX ST AMAND LES EAUX, BIODEX ST AMAND LES EAUX filed Critical BIODEX ST AMAND LES EAUX
Publication of DE69831805D1 publication Critical patent/DE69831805D1/de
Application granted granted Critical
Publication of DE69831805T2 publication Critical patent/DE69831805T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69831805T 1997-12-11 1998-12-11 Dextranderivate, verfahren zu deren herstellung und verwendungen als arzneimittel mit spezifischer, biologischer wirkung Expired - Lifetime DE69831805T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9715702 1997-12-11
FR9715702A FR2772382B1 (fr) 1997-12-11 1997-12-11 Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique
PCT/FR1998/002699 WO1999029734A1 (fr) 1997-12-11 1998-12-11 Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique

Publications (2)

Publication Number Publication Date
DE69831805D1 true DE69831805D1 (de) 2006-02-16
DE69831805T2 DE69831805T2 (de) 2008-01-24

Family

ID=9514480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831805T Expired - Lifetime DE69831805T2 (de) 1997-12-11 1998-12-11 Dextranderivate, verfahren zu deren herstellung und verwendungen als arzneimittel mit spezifischer, biologischer wirkung

Country Status (9)

Country Link
US (1) US6646120B1 (de)
EP (1) EP0990002B1 (de)
JP (1) JP2001523300A (de)
AT (1) ATE305942T1 (de)
AU (1) AU1567799A (de)
CA (1) CA2280949C (de)
DE (1) DE69831805T2 (de)
FR (1) FR2772382B1 (de)
WO (1) WO1999029734A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
FR2794976B1 (fr) * 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
DE10064827A1 (de) 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Nachweisverfahren
FR2832708B1 (fr) * 2001-11-29 2004-02-13 Organes Tissus Regeneration Re Procede de sulfonation de composes comprenant des groupements hydroxyle (oh) libres ou des amines primaires ou secondaires
US7172906B2 (en) * 2004-11-16 2007-02-06 Dade Behring Inc. Reduction of non-specific binding in assays
FR2914305B1 (fr) * 2007-03-29 2009-07-03 Proteins & Peptides Man Dextran fonctionnalise par des amino-acides hydrophobes.
FR2891149B1 (fr) * 2005-09-26 2007-11-30 Biodex Sarl Composition pharmaceutique a action cicatrisante comprenant un derive de dextrane soluble et un facteur de croissance derive des plaquettes.
CA2648395A1 (fr) * 2006-04-07 2007-10-18 Adocia Polysaccharides bifonctionnalises
FR2914191A1 (fr) * 2007-03-29 2008-10-03 Proteins & Peptides Man Composition angiogenique.
FR2919188B1 (fr) * 2007-07-27 2010-02-26 Proteins & Peptides Man Complexes entre un polymere amphiphile et une proteine osteogenique appartenant a la famille des bmps
FR2934999B1 (fr) * 2008-08-13 2011-07-29 Adocia Polysaccharides fonctionnalises par des derives du tryptophane
FR2966248B1 (fr) 2010-10-18 2020-05-01 Centre National De La Recherche Scientifique (Cnrs) Procede de fonctionnalisation de surfaces pour la detection d'analytes
CN102863550B (zh) * 2012-10-25 2014-06-18 西南大学 辛烯基琥珀酸魔芋葡甘聚糖酯制备方法
FR3025428A1 (fr) 2014-09-08 2016-03-11 Adocia Composition pharmaceutique stable comprenant du pdgf
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
AU2016243411B2 (en) 2015-04-03 2020-10-22 Nutrition & Biosciences USA 4, Inc. Gelling dextran ethers
US10787524B2 (en) 2015-04-03 2020-09-29 Dupont Industrial Biosciences Usa, Llc Oxidized dextran
BR112019012235B1 (pt) 2016-12-16 2022-10-18 Nutrition & Biosciences Usa 4, Inc Composição e método para o tratamento de um substrato

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1152396B (de) * 1960-01-26 1963-08-08 Bernburg Serum Werk Veb Verfahren zur Herstellung von Natriumsalzen blutgerinnungshemmender Dextranschwefelsaeureester
FR2461724A1 (fr) * 1979-07-20 1981-02-06 Christine Fougnot Polymeres substitues par des groupes leur conferant des proprietes anti-coagulantes et leur procede de preparation, objets constitues par et/ou comprenant lesdits polymeres et leurs procedes de fabrication, application desdits objets en chirurgie et en medecine, et compositions pharmaceutiques contenant lesdits polymeres substitues
FR2555589B1 (fr) * 1983-11-30 1986-05-16 Choay Sa Nouveaux derives du dextrane a activites anticoagulante en anti-inflammatoire, leur procede de preparation et utilisation de ces derives en tant qu'anticoagulants et en tant que substituts du plasma sanguin
FR2644066B1 (fr) * 1989-03-09 1994-05-13 Therapeutiques Substitutives Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques
FR2651436B1 (fr) * 1989-09-05 1994-09-09 Sanofi Sa Compositions pharmaceutiques contenant un derive substitue soluble de dextrane.
FR2657782B1 (fr) * 1990-02-06 1992-05-22 Therapeutiques Substitutives Nouvel agent antitumoral derive du dextrane.

Also Published As

Publication number Publication date
FR2772382A1 (fr) 1999-06-18
AU1567799A (en) 1999-06-28
ATE305942T1 (de) 2005-10-15
EP0990002B1 (de) 2005-10-05
WO1999029734A1 (fr) 1999-06-17
CA2280949C (fr) 2011-03-22
CA2280949A1 (fr) 1999-06-17
DE69831805T2 (de) 2008-01-24
US6646120B1 (en) 2003-11-11
FR2772382B1 (fr) 2000-03-03
EP0990002A1 (de) 2000-04-05
JP2001523300A (ja) 2001-11-20

Similar Documents

Publication Publication Date Title
DE69831805D1 (de) Dextranderivate, verfahren zu deren herstellung und verwendungen als arzneimittel mit spezifischer, biologischer wirkung
BR0007980A (pt) Processo para a preparação de derivadosmulti-reticulados de ácido hialurÈnico, hamulti-reticulado, ha reticulado em si próprio,produto, e, uso de ha
BR0007985A (pt) Processo para a preparação de derivados multiplamente reticulados do ácido hialurÈnico (ha), ha multiplamente reticulado, ha reticulado em um ou mais polìmeros diferentes de ha, ha reticulado em um segundo polìmero, produto, e, uso de um derivado de ha multiplamente reticulado
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
AU3310595A (en) Compositions and methods for identifying biologically active molecules
BR9713468A (pt) Processo para a polimerização de alfa-olefinas, catalisador usado na polimerização e sua preparação.
FI103381B1 (fi) Hyaluronihapon veteen liukenemattomia geelejä ja menetelmä sen valmistamiseksi
BR9608041A (pt) Oligossacarídeo sulfatado processo para o tratamento anti-angiogênico anti-metastático e/ou anti-inflamatório de um paciente humano ou outro paciente animal de sangue quente uso de um oligossacarídeo e composição farmacêutica ou veterinária para tratamento anti-angiogênico anti-metastático e/ou anti-inflamatório
AU7576896A (en) Lipopolyamines as transfection agents and their pharmaceutical applications
DE59303365D1 (de) Derivate in der vitamin d-reihe mit modifikationen in der 20 position, verfahren zu ihrer herstellung, zwischenprodukte für dieses verfahren, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
BG102312A (en) New derivatives of 5-oxy-deoaminyl 6-oxy-methyl erythronolide a, method for their preparation and application for the preparation of biologically active products
ES8501414A1 (es) Procedimiento de sintesis organica de oligosacaridos
GR3023541T3 (en) N,O-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them
ATE241648T1 (de) Buttersäure-ester mit antiproliferativer wirkung und diese enthaltende pharmazeutische zusammensetzungen
BR9406126A (pt) Produto pseudo-dipeptícico,processo químico e enzimático de preparação do mesmo aplicação do produto e medicamento
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
BR9407971A (pt) Produto pseudodipeptideo processo químico e enzimático de preparaçao do mesmo aplicaçao do produto e medicamento resultante da aplicaçao
DE69316758T2 (de) Selbstvernetztes gellangummi
ATE27914T1 (de) Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
ATE363909T1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
FI102169B (fi) 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lää keaineina
ATE66610T1 (de) Primycin enthaltendes kolloidales grundgel, verfahren zu dessen herstellung, dieses grundgel enthaltende pharmazeutische und pharmako- kosmetische kompositionen.
MY114693A (en) Substituted benzenesulfonylureas and thioureas,processes for their preparation,their use for the production of pharmaceutical preparations, and pharmaceutical preparation containing them

Legal Events

Date Code Title Description
8332 No legal effect for de
8328 Change in the person/name/address of the agent

Representative=s name: BOHMANN & LOOSEN, 80335 MUENCHEN

8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIODEX, LYON, FR